Matthew Szot
Board Member
Cadrenal Therapeutics, Inc. (CVKD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cadrenal Therapeutics, Inc. (CVKD) | Former Chief Financial Officer | $459,716 | $1,307,019 |
| 2024 | Cadrenal Therapeutics, Inc. (CVKD) | Chief Financial Officer | $435,850 | $868,279 |
| 2023 | Cadrenal Therapeutics, Inc. (CVKD) | Chief Financial Officer | $377,180 | $844,890 |
| 2022 | Cadrenal Therapeutics, Inc. (CVKD) | Chief Financial Officer | — | $359,605 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.